Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT01500395
Other study ID # XJ-20111126 -2
Secondary ID
Status Recruiting
Phase N/A
First received December 22, 2011
Last updated December 30, 2015
Start date November 2011
Est. completion date December 2018

Study information

Verified date December 2015
Source Xijing Hospital
Contact Jian Yang, MD,PhD
Phone 86-13892828016
Email yangjian1212@hotmail.com
Is FDA regulated No
Health authority China: Food and Drug Administration
Study type Observational [Patient Registry]

Clinical Trial Summary

The purpose of this study is to investigate the short to mid term efficacy and safety of different hybrid operations who had complex aortic lesions, such as ascending aortic/arch aneurysm, pseudo-aneurysm, Stanford Type A dissection, retrograde Stanford Type B dissection, dissection with primary tear located in the aortic arch, et al.


Description:

Aneurysms and dissection involving the ascending aorta and aortic arch have historically been treated with open surgical techniques, requiring cardiopulmonary bypass and deep hypothermic circulatory arrest (DHCA). Despite increasing experience and refinement of these procedures, there remains a substantial rate of morality and morbidity. The goal of hybrid operations is to re-construct the ascending aorta and aortic arch to cover the primary entry tear of the dissection and to remodel the aorta. Hybrid Operations including debranching technique+Thoracic Endovascular Aortic Repair (TEVAR), Frozen elephant trunk technique, aortic arch replacement with concommitant TEVAR, et al. The purpose of this study is to investigate the short to mid term efficacy and safety of different hybrid operations who had complex aortic lesions, such as ascending aortic/arch aneurysm, pseudo-aneurysm, Stanford Type A dissection, retrograde Stanford Type B dissection, dissection with primary tear located in the aortic arch, et al.

Primary outcome measure is all-cause mortality. Secondary outcome variables include conversion to stent and/or surgery, induced thrombosis of the false lumen, cardiovascular morbidity, aortic expansion (>5 mm/y of maximum diameter including true and false lumina), quality of life, and length of intensive care unit and hospital stay. The study designs to enroll 50 patients to be monitored for 24 months.


Recruitment information / eligibility

Status Recruiting
Enrollment 50
Est. completion date December 2018
Est. primary completion date December 2015
Accepts healthy volunteers No
Gender Both
Age group 12 Years to 90 Years
Eligibility Inclusion CriteriaInclusion Criteria:

- Ascending aortic/arch aneurysm

- Ascending aortic/arch pseudo-aneurysm

- Stanford Type A dissection

- Retrograde Stanford Type B dissection

- Unclassified dissection with primary tear located in the aortic arch

- Able to tolerate endotracheal intubation and general anesthesia

- Subject's anatomy must meet the anatomical criteria to receive that implanted device

- The subject or legal guardian understands the nature of the study and agrees to its provisions on a written informed consent form

- Availability for the appropriate follow-up visits during the follow-up period

- Capability to follow all study requirements

Exclusion Criteria:

- ASA classification = V

- Severe renal insufficiency defined as SVS risk renal status = 3

- Severe respiratory insufficiency defined as SVS risk pulmonary status = 3

- Presence of connective tissue disease

- Active infection or active vasculitides

- Pregnant woman or positive pregnancy test

- Myocardial infarction or cerebrovascular accident within 6 weeks prior to study enrollment

- Subject has had a cerebral vascular accident (CVA) within 2 months.

- History of drug abuse

- Subject has a history of bleeding diathesis, coagulopathy, or refuses blood transfusion.

- Subject has a known allergy or intolerance to the device components.

- Subject has a known hypersensitivity or contraindication to anticoagulants or contrast media, which is not amenable to pre-treatment.

- Subject has a co-morbidity causing expected survival to be less than 1 year.

- Enrolment in another clinical study

- Unwillingness to cooperate with study procedures or follow-up visits

Study Design

Observational Model: Case-Only, Time Perspective: Prospective


Related Conditions & MeSH terms


Intervention

Procedure:
Hybrid operation
Hybrid Operations including debranching technique+Thoracic Endovascular Aortic Repair (TEVAR), Frozen elephant trunk technique, aortic arch replacement with concommitant TEVAR, et al. Devices include Medtronic Stent Graft(Medtronic Medtronic, Inc., US) Microport Stent Graft(Microport Co.,LTD.,Shanghai, China) Ankura Stent Graft(Lifetech Scientific Co.,LTD.,Shenzhen, China).

Locations

Country Name City State
China Department of Cardiovascular Surgery of Xijing Hospital, Fourth Military Medical University Xi'an Shaanxi

Sponsors (3)

Lead Sponsor Collaborator
Xijing Hospital Changhai Hospital, Shanghai Zhongshan Hospital

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary Cumulative MACE Cumulative MACE (including death, rupture, paraplegia, aneurysm formation et al) 12 months Yes
Secondary Endoleak Endoleak of all types from the stent graft 12 months Yes
Secondary Stent-graft migration/kinking Stent-graft migration, stenosis, kinking and other conditions requiring re-intervention 12 months Yes
Secondary Cumulative cerebrovascular events Cumulative cerebrovascular events as bleeding, thrombosis, paraplegia, transient unconsciousness, et al. 12 months Yes
Secondary Liver/Kidney dysfunction Liver dysfunction including jaundice,transaminase elevation 1.5 times more than normal, et al.
Kidney dysfunction including oliguria, anuria, Creatinine/BUN elevation 1.5 times more than normal, et al.
12 months Yes
See also
  Status Clinical Trial Phase
Completed NCT04564560 - Graft Thrombosis After Endovascular Aortic Repair - a Single Center Experience With the Cook Zenith Alpha Spiral-Z®
Recruiting NCT01496833 - Total Endovascular Aortic Arch Re-construction Study(TEARS) N/A
Recruiting NCT01505309 - Endovascular Aortic Repair for Aortic Dissection N/A
Completed NCT06187051 - Type 1 Endoleak : Fenestrated Custom Made Endograft (FEVAR) Versus Open Surgery Explantation (OSR) : What's the Best
Withdrawn NCT01480531 - Pre and or Post Operative Blood Pressure Control With Clevidipine (Cleviprexm Medicines Company) in Aortic Aneurysm / Dissection N/A
Not yet recruiting NCT04307888 - Spanish Percutaneous Aortic INtervention REGISTRY (SPAIN REGISTRY)